Neogen (NEOG) to Release Quarterly Earnings on Thursday

Neogen (NASDAQ:NEOG) is expected to be announcing its Q4 2026 results before the market opens on Thursday, July 30th. Analysts expect Neogen to post earnings of $0.05 per share and revenue of $212.35 million for the quarter. Individuals can check the company’s upcoming Q4 2026 earning report for the latest details on the call scheduled for Thursday, July 30, 2026 at 8:00 AM ET.

Neogen Price Performance

NEOG stock traded up $0.04 during midday trading on Tuesday, reaching $9.38. The company had a trading volume of 274,236 shares, compared to its average volume of 2,779,918. The firm has a 50-day moving average price of $9.29 and a 200-day moving average price of $9.58. The company has a market capitalization of $2.04 billion, a P/E ratio of -3.35, a P/E/G ratio of 4.21 and a beta of 1.80. Neogen has a 1 year low of $4.56 and a 1 year high of $11.43. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.92 and a quick ratio of 2.84.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Mercer Global Advisors Inc. ADV grew its position in Neogen by 10.1% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 17,837 shares of the company’s stock worth $125,000 after acquiring an additional 1,638 shares during the last quarter. Brooklyn Investment Group bought a new stake in Neogen in the fourth quarter valued at approximately $111,000. Gallagher Fiduciary Advisors LLC lifted its position in Neogen by 20.5% in the second quarter. Gallagher Fiduciary Advisors LLC now owns 22,737 shares of the company’s stock valued at $109,000 after purchasing an additional 3,867 shares during the last quarter. Jain Global LLC purchased a new stake in shares of Neogen during the third quarter valued at approximately $106,000. Finally, Boothbay Fund Management LLC purchased a new stake in shares of Neogen during the second quarter valued at approximately $103,000. Hedge funds and other institutional investors own 96.73% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on NEOG. Wall Street Zen upgraded shares of Neogen from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Weiss Ratings downgraded Neogen from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday. Two research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $10.67.

About Neogen

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.